摘要
目的探讨踝肱指数(ABI)在评价抗动脉粥样硬化治疗中的应用价值。方法选择45例动脉粥样硬化疾病(冠心病、缺血性卒中、下肢闭塞性动脉硬化等)患者,比较治疗前后的ABI以及血清总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL-C)水平。结果入组患者经抗动脉粥样硬化治疗后,其ABI(右侧0.95±0.22,左侧1.00±0.15)较治疗前(右侧0.88±0.26,左侧0.89±0.20)相比明显升高(P<0.01),治疗后的总胆固醇、低密度脂蛋白水平较前下降,差异有统计学意义(P<0.01)。结论 ABI是一种简单、实用及无创的评价动脉粥样硬化的方法,可作为抗动脉粥样硬化治疗效果的评价指标。
Objective To investigate the application value of Ankle-arm index(ABI)in the evaluation of therapeutic effect of anti atherosclerosis.Methods 45 cases of patients with atherosclerotic disease(coronary heart disease,ishemic stroke or lower extremity atherosclerotic occlusive disease)were selected and accepted anti-atherosclerosis treatment.The ABI value and blood total Cholesterol(TC),triglyceride(TG)and low density lipoprotein cholesterol(LDL-C)level before and after the treatment were compared.Results After the treatment of atherosclerosis in the group,The level of ABI(right 0.95±0.22,left 1.00±0.15)was significantly higher(P<0.01)than before(right 0.88±0.26,left 0.89±0.20)the treatment and the level of total cholesterol and low density lipoprotein were lower than before the treatment,and the difference was statistically significant(P<0.01).Conclusion The ABI value is a simple,practical and noninvasive method for the assessment of atherosclerosis,which can be used as evaluation index of therapeutic effect of anti-atherosclerosis.
作者
王书
张颖
张杰
苏增峰
严光
Wang Shu;Zhang Ying;Zhang Jie;Su Zengfeng;Yan Guang(Department of Geriatrics,Hefei Binhu Hospital,Hefei 230061,China)
出处
《中国临床保健杂志》
CAS
2018年第2期182-184,共3页
Chinese Journal of Clinical Healthcare
基金
安徽省科技厅2015年公益性技术应用研究联动计划项目(15011d04062)
关键词
冠状动脉疾病
踝肱指数
胆固醇
脂蛋白类
LDL
Coronary artery disease
Ankle brachial index
Cholesterol
Lipoproteins
LDL
